Market Closed -
Nasdaq Stockholm
11:29:49 2024-05-02 am EDT
|
5-day change
|
1st Jan Change
|
1.218
SEK
|
+1.84%
|
|
-2.25%
|
+115.19%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
106.4
|
236.9
|
162.8
|
117.3
|
23.47
|
117
|
Enterprise Value (EV)
1 |
102.8
|
225
|
154.2
|
99.47
|
26.34
|
100.3
|
P/E ratio
|
-7.19
x
|
-15.7
x
|
-23.8
x
|
-10.6
x
|
-0.79
x
|
115
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
7.52
x
|
9.79
x
|
6.17
x
|
5.34
x
|
1.13
x
|
1.77
x
|
EV / Revenue
|
7.27
x
|
9.3
x
|
5.84
x
|
4.53
x
|
1.27
x
|
1.52
x
|
EV / EBITDA
|
-7.67
x
|
-14.1
x
|
-22.9
x
|
-9.63
x
|
-0.88
x
|
84.2
x
|
EV / FCF
|
-
|
-
|
-108,392,433
x
|
-10,287,925
x
|
-1,570,693
x
|
-52,413,898
x
|
FCF Yield
|
-
|
-
|
-0%
|
-0%
|
-0%
|
-0%
|
Price to Book
|
2.52
x
|
5.07
x
|
3.71
x
|
2.09
x
|
0.88
x
|
2.44
x
|
Nbr of stocks (in thousands)
|
64,119
|
64,119
|
71,244
|
83,816
|
83,816
|
206,700
|
Reference price
2 |
1.660
|
3.695
|
2.285
|
1.400
|
0.2800
|
0.5660
|
Announcement Date
|
3/28/19
|
4/6/20
|
4/8/22
|
4/8/22
|
4/6/23
|
4/5/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
14.15
|
24.2
|
26.4
|
21.97
|
20.73
|
66.02
|
EBITDA
1 |
-13.41
|
-15.97
|
-6.728
|
-10.33
|
-30.03
|
1.191
|
EBIT
1 |
-13.76
|
-16.27
|
-7.101
|
-10.68
|
-30.24
|
1.036
|
Operating Margin
|
-97.21%
|
-67.22%
|
-26.9%
|
-48.59%
|
-145.9%
|
1.57%
|
Earnings before Tax (EBT)
1 |
-12.33
|
-15.68
|
-6.726
|
-10.26
|
-29.49
|
0.752
|
Net income
1 |
-12.33
|
-15.68
|
-6.73
|
-10.25
|
-29.57
|
0.715
|
Net margin
|
-87.13%
|
-64.81%
|
-25.49%
|
-46.65%
|
-142.64%
|
1.08%
|
EPS
2 |
-0.2308
|
-0.2355
|
-0.0959
|
-0.1322
|
-0.3527
|
0.004922
|
Free Cash Flow
|
-
|
-
|
-1.423
|
-9.668
|
-16.77
|
-1.914
|
FCF margin
|
-
|
-
|
-5.39%
|
-44%
|
-80.91%
|
-2.9%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/28/19
|
4/6/20
|
4/8/22
|
4/8/22
|
4/6/23
|
4/5/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
2.87
|
-
|
Net Cash position
1 |
3.61
|
11.9
|
8.58
|
17.9
|
-
|
16.7
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-0.0957
x
|
-
|
Free Cash Flow
|
-
|
-
|
-1.42
|
-9.67
|
-16.8
|
-1.91
|
ROE (net income / shareholders' equity)
|
-32.1%
|
-33.8%
|
-14.3%
|
-20.5%
|
-71.5%
|
1.92%
|
ROA (Net income/ Total Assets)
|
-17.5%
|
-18.4%
|
-7.52%
|
-10.9%
|
-31.7%
|
1.15%
|
Assets
1 |
70.51
|
85.04
|
89.53
|
94.33
|
93.16
|
61.98
|
Book Value Per Share
2 |
0.6600
|
0.7300
|
0.6200
|
0.6700
|
0.3200
|
0.2300
|
Cash Flow per Share
2 |
0.0900
|
0.2200
|
0.1600
|
0.2300
|
0.0200
|
0.0900
|
Capex
|
-
|
-
|
0.25
|
0.28
|
0.03
|
0.32
|
Capex / Sales
|
-
|
-
|
0.95%
|
1.27%
|
0.14%
|
0.48%
|
Announcement Date
|
3/28/19
|
4/6/20
|
4/8/22
|
4/8/22
|
4/6/23
|
4/5/24
|
|
1st Jan change
|
Capi.
|
---|
| +115.19% | 22.53M | | +9.12% | 33.76B | | +14.77% | 7.72B | | +3.93% | 7.03B | | +19.03% | 5.36B | | -3.97% | 4.14B | | +38.58% | 4.07B | | +15.15% | 3.77B | | +5.14% | 3.42B | | -11.08% | 2.64B |
Testing & Measuring Equipment
|